HRMY Harmony Biosciences

• None no insider bought on the open market
• None no sales outside a trading plan
• $6M sold by 3 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Kumar Budur Chief Medical Officer
   Planned sale
   $1.7M 38,452 shares at $43.05 75% of stake
   Traded Sep 16–18 Filed Sep 18
   ↗
3. Kumar Budur Chief Medical Officer
   Planned sale
   $1.5M 33,954 shares at $42.80 72% of stake
   Traded Sep 4–8 Filed Sep 9
   ↗
4. Sandip Kapadia CFO
   Planned sale
   $139K 3,746 shares at $37.15 13% of stake
   Traded Jan 26 Filed Jan 28
   ↗
5. Sandip Kapadia CFO
   Planned sale
   $753K 20,961 shares at $35.92 100% of stake
   Traded Jan 15 Filed Jan 20
   ↗
6. Jeffrey M. Dayno CEO
   Planned sale
   $1M 25,933 shares at $40.11 100% of stake
   Traded Dec 12, 2025 Filed Dec 17, 2025
   ↗
7. Sandip Kapadia CFO
   Planned sale
   $791K 20,000 shares at $39.54 100% of stake
   Traded Dec 5, 2025 Filed Dec 9, 2025
   ↗
8. Sandip Kapadia CFO
   Planned sale
   $120K 3,427 shares at $35.00 100% of stake
   Traded Nov 21, 2025 Filed Nov 25, 2025
   ↗

Also filed in the last 12 months, not counted as buying or selling: 20 option exercises and 10 share withholdings for taxes.